Overview

Feasibility Study of Take-Home LAAM Medication - 3

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test therapeutic benefits of take-home LAAM. (1) Do subjects with take-home LAAM availability show increased clinical responsibility over subjects without; (2) Do subjects with take-home LAAM attempt diversion when random recall and other diversion safeguards are used; (3) Does treatment response correlate with background or drug use variables at intake, discharge, or during treatment?
Phase:
Phase 4
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
University of California, Los Angeles
Collaborator:
National Institute on Drug Abuse (NIDA)